MARSHALL WACE, LLP - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 120 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2022$81,000
-82.5%
56,525
-36.2%
0.00%
-100.0%
Q4 2021$464,000
+329.6%
88,624
+380.3%
0.00%
Q3 2021$108,000
-52.0%
18,451
-32.0%
0.00%
-100.0%
Q1 2021$225,000
-28.3%
27,127
-34.4%
0.00%
-50.0%
Q4 2020$314,000
-81.5%
41,363
-63.0%
0.00%
-83.3%
Q2 2020$1,694,000
+472.3%
111,739
+214.8%
0.01%
+300.0%
Q1 2020$296,000
-53.5%
35,500
+17.2%
0.00%0.0%
Q1 2019$636,000
+198.6%
30,288
+225.7%
0.00%
-66.7%
Q1 2018$213,0009,3000.01%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Birchview Capital, LP 2,183,795$49,965,00030.39%
ORACLE INVESTMENT MANAGEMENT INC 4,356,363$99,674,00021.44%
Selkirk Management LLC 348,805$7,981,0004.29%
Trellus Management Company, LLC 55,502$1,270,0001.72%
GRIFFIN ASSET MANAGEMENT, INC. 550,046$12,585,0001.60%
Belpointe Asset Management LLC 272,459$6,234,0001.23%
Cannell & Co. 1,115,239$25,517,0000.97%
CHARTIST INC /CA/ 64,765$1,481,823,0000.94%
Chicago Capital, LLC 546,279$12,499,0000.80%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$3,546,0000.76%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders